Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: Results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season☆☆☆★

Authors:
  • MKMarianne Kronqvist
    Marianne Kronqvist
  • OZOlle Zetterström
    Olle Zetterström
  • EJEva Johansson
    Eva Johansson
  • VNVerena Niederberger
    Verena Niederberger
  • RGReidar Grönneberg
    Reidar Grönneberg
  • RVRudolf Valenta
    Rudolf Valenta

Abstract
No abstract available